Author

B. Sawatsky

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:rat· 1

Frequent Co-Authors

C. K. Pfaller· 2 shared K. Wittwer· 2 shared A. A. Hennrich· 1 shared A. Kratzel· 1 shared A. Moreira - Soto· 1 shared A. Schopf· 1 shared A. Vicente - Santos· 1 shared C. Gurtner· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. K. Pfaller

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintNov 2, 2022

Non-neutralizing antibody responses to vesicular stomatitis virus-vectored influenza A virus vaccines correlate with protection

K. Wittwer, G. Zimmer, M. Rommel…·C. K. Pfaller

This study shows that non-neutralizing antibodies against conserved IAV antigens like NP and M2 provide cross-protection against different IAV strains in mice.

DOI 10.1101/2022.11.02.514911

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintNov 10, 2020

Susceptibility of well-differentiated airway epithelial cell cultures from domestic and wildlife animals to SARS-CoV-2

M. Gultom, M. Licheri, L. Laloli…·R. Dijkman

This study assesses the susceptibility of airway epithelial cell cultures from various animals to SARS-CoV-2, finding efficient replication only in monkey and cat models.

DOI 10.1101/2020.11.10.374587

humanmouse

𝕏 PostBluesky

MicrobiologybioRxivPreprintOct 2, 2020

Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19

A. A. Hennrich, D. H. Banda, M. Oberhuber…·K.-K. Conzelmann

This paper develops a safe and effective vaccine platform using rhabdovirus replicons that present the SARS-CoV-2 RBD as VLPs, inducing strong neutralizing antibodies in mice.

DOI 10.1101/2020.10.02.324046

mouseexperimental assay

𝕏 PostBluesky